StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$278.70−3.85 (-1.36%)

Close on Nov 17, 2026Market cap $670.92BP/E 42.3Yield 1.84%

Johnson & Johnson enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Johnson & Johnson's enterprise value was $712.82B on Nov 11, 2026, against $529.05B a year earlier. Over the last 5 years it ranged from $366.57B to $712.82B, with a median of $444.60B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$712.82B+34.7%
2025Dec 31, 2025$529.12B+44.3%
2024Dec 31, 2024$366.57B-11.7%
2023Dec 29, 2023$415.26B-11.5%
2022Dec 30, 2022$469.02B+1.9%
2021Dec 31, 2021$460.09B+7.7%
2020Dec 31, 2020$427.13B+5.6%
2019Dec 31, 2019$404.63B+11.1%
2018Dec 31, 2018$364.29B-9.6%
2017Dec 29, 2017$403.15B+30.6%
2016Dec 30, 2016$308.67B+13.4%
2015Dec 31, 2015$272.30B-9.7%
2014Dec 31, 2014$301.67B+15.8%
2013Dec 31, 2013$260.50B+32.3%
2012Dec 31, 2012$196.94B+6.1%
2011Dec 30, 2011$185.63B+8.1%
2010Dec 31, 2010$171.79B-4.3%
2009Dec 31, 2009$179.51B–

More Johnson & Johnson figures

See a number that looks wrong?